<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="Ltd. S0882-4010(20)30528-3 doi: 10.1016/j.micpath.2020.104241104241 : Article Study of combining virtual" exact="screening" post="and antiviral treatments of the Sars-CoV-2 (Covid-19) KhodadadiEhsanehehsaneh.khodadadi@gmail.comaMaroufiParhamDr.parhammaroufi@yahoo.combKhodadadiEhsanE.khodadadi@yahoo.comcEspositoIsabellaIsabellaesposito@libero.itdGanbarovKhudaverdiKhuda1949@mail.rueEspsoitoSilvanosilvanoesposito@libero.itdYousefiMehdiyousefime@tbzmed.ac.irfZeinalzadehElhamElham_leyenda@yahoo.comgKafilHossein SamadiKafilhs@tbzmed.ac.iraâˆ—[a],"/>
 <result pre="and host receptor recognition, a crucial factor for successful virus" exact="infection" post="and taking immune-informatics approaches to identify B- and T-cell"/>
 <result pre="and clinicians in developing better techniques for timely and effective" exact="detection" post="of coronavirus infection. Moreover, the genomic sequence of the"/>
 <result pre="this review to identify potential drugs. â€¢Using virtual high throughput" exact="screening" post="will help to identify potential drugs. Keywords Coronavirus SARS-CoV-2"/>
 <result pre="acute respiratory syndrome coronavirus (SARS-CoV). The symptoms caused by Sars-CoV-2" exact="infection" post="include acute respiratory distress syndrome (~29%), acute cardiac injury"/>
 <result pre="been done to understand the molecular basis of the coronavirus" exact="infection" post="and evolution, develop an effective treatment in forms of"/>
 <result pre="basis of the coronavirus infection and evolution, develop an effective" exact="treatment" post="in forms of both vaccines and antiviral drugs, and"/>
 <result pre="vaccines and antiviral drugs, and propose efficient measures for viral" exact="detection" post="and prevention [[11], [12], [13]]. Structures of many individual"/>
 <result pre="and host proteins, have been explored along with the experimental" exact="testing" post="of anti-viral properties of small compounds [[14], [15], [16]]."/>
 <result pre="and host proteins, have been explored along with the experimental" exact="testing" post="of anti-viral properties of small compounds [16]. However, experimental"/>
 <result pre="target host cells via binding host receptors before engaging the" exact="infection" post="cycle. ACE2 was proved to be the cell receptor"/>
 <result pre="is also a peptidase, despite that its involvement in virus" exact="infection" post="is unclear. For mysterious reasons, human coronaviruses use peptidases"/>
 <result pre="target similar cell types across different human tissues. 6 General" exact="treatment" post="for viral infection Currently, there is no registered treatment"/>
 <result pre="types across different human tissues. 6 General treatment for viral" exact="infection" post="Currently, there is no registered treatment or vaccine for"/>
 <result pre="General treatment for viral infection Currently, there is no registered" exact="treatment" post="or vaccine for the disease. In the absence of"/>
 <result pre="vaccine for the disease. In the absence of a specific" exact="treatment" post="for this novel virus, there is an urgent need"/>
 <result pre="D status in calves had been reported to cause the" exact="infection" post="of Bovine coronavirus [81]. Vitamin E deficiency had been"/>
 <result pre="myocardial injury of coxsackievirus B3 (a kind of RNA viruses)" exact="infection" post="in mice [82]. Protection D1, the omega-3 PUFA-derived lipid"/>
 <result pre="interferon-Î±-2a with ribavirin was administered to patients with severe MERS-CoV" exact="infection" post="and the survival of these patients was improved [87]."/>
 <result pre="binding of S protein to ACE2 is important for the" exact="treatment" post="of SARS-CoV infection [102]. One recombinant human monoclonal antibody"/>
 <result pre="protein to ACE2 is important for the treatment of SARS-CoV" exact="infection" post="[102]. One recombinant human monoclonal antibody (mAb) (single-chain variable"/>
 <result pre="antiviral effects. In addition, it had been used against viral" exact="infection" post="[104]. Emodin is an anthraquinone compound derived from genus"/>
 <result pre="compound derived from genus Rheum boosted protease inhibitor in the" exact="treatment" post="of HIV infection. Lopinavir (LPV) is usually combined with"/>
 <result pre="emodin, and promazine could be used as choices for the" exact="treatment" post="of COVID-19. Nicotianamine is an important metal-ligand in plants"/>
 <result pre="is another potential option to be used to reduce the" exact="infection" post="of COVID-19. 6.4 Antiviral treatments Ribavirin, a broad-spectrum antiviral"/>
 <result pre="the use of ribavirin should be seriously considered for the" exact="treatment" post="of COVID-19, even in combination with other antiviral drugs."/>
 <result pre="is widely used as a boosted protease inhibitor in the" exact="treatment" post="of HIV infection [112]. Kim et al. [113] had"/>
 <result pre="as a boosted protease inhibitor in the treatment of HIV" exact="infection" post="[112]. Kim et al. [113] had also reported a"/>
 <result pre="RDV with IFN-Î² could be a better choice for the" exact="treatment" post="of COVID-19 comparing with that of the triple combination"/>
 <result pre="inhalation could be also chosen as an option for the" exact="treatment" post="of severely COVID-19 infected patients (Table 1 ). Table"/>
 <result pre="Compounds Virus target Functions Representative References General treatments for viral" exact="infection" post="Nutritional interventions Vitamin A Measles virus, avian coronavirus Prevention"/>
 <result pre="(Cauwenberghs, Feijge et al., 2006) Nicotianamine SARSâ€�CoV To reduce the" exact="infection" post="(Cauwenberghs, Feijge et al., 2006) Antiviral treatments Ribavirin SARSâ€�CoV"/>
 <result pre="Erdman et al., 2003) (LPV)b/(RTV)c (Kaletra) MERSâ€�CoV Treatment of HIV" exact="infection" post="(Tsang and Zhong 2003) Remdesivir SARSâ€�CoV/MERSâ€�CoV Treatment of Ebola"/>
 <result pre="HIV (Mohanasundaram and Sekhar 2018) Arbidol SARSâ€�CoV Treatment for influenza" exact="infection" post="(Khamitov, Loginova et al., 2008) Nitric oxide SARSâ€�CoV Treatment"/>
 <result pre="Prediction of potential drugs for COVID-19 7.1 Virtual high throughput" exact="screening" post="Computational methods can be utilized for the design and"/>
 <result pre="time requirements of computational methods are conducive for high throughput" exact="screening" post="of available drugs to identify potential drugs for novel"/>
 <result pre="attractive. However, clinical trials are necessary to ensure that such" exact="treatment" post="is better than a placebo [125]. Lopinavir and Ritonavir"/>
 <result pre="structure of SARS-CoV-2 Mpro [123,127]. However, the predictions of virtual" exact="screening" post="studies and binding energy calculations are generally more accurate"/>
 <result pre="Mpro was utilized as the target for virtual high throughput" exact="screening" post="[120], indicating that the results confirm earlier preliminary reports"/>
 <result pre="of homologs that some of the drugs approved for the" exact="treatment" post="of other viral infections also have the potential for"/>
 <result pre="of other viral infections also have the potential for the" exact="treatment" post="of COVID-19. Therefore, approved anti-viral drugs that target proteases"/>
 <result pre="increase of patients and a high mortality rate of Sars-CoV-2" exact="infection" post="highlight the urgent need for the development of a"/>
 <result pre="but there are no licensed therapeutic or vaccine for the" exact="treatment" post="of SARS-CoV-2 infection available in the market. Developing an"/>
 <result pre="no licensed therapeutic or vaccine for the treatment of SARS-CoV-2" exact="infection" post="available in the market. Developing an effective treatment for"/>
 <result pre="of SARS-CoV-2 infection available in the market. Developing an effective" exact="treatment" post="for SARS-CoV-2 is, therefore, a research priority. It is"/>
 <result pre="viral infection, T-cell and antibody reactions may recover extreme respiratory" exact="infection" post="(Fig. 2 ). Fig. 2 The overall workflow of"/>
 <result pre="of treatment. Therefore, it is necessary to find and evaluate" exact="treatment" post="methods more quickly in this case computer methods are"/>
 <result pre="to interpret the results of ongoing clinical trials that are" exact="testing" post="existing drugs for effectiveness against COVID-19. Notwithstanding the limitations,"/>
 <result pre="quick overview and comparison with other emerging virusesMicrob. Infect.22220206971 10LuH.Drug" exact="treatment" post="options for the 2019-new coronavirus (2019-nCoV)Biosci. Trends142020697131996494 11YuanY.CaoD.ZhangY.MaJ.QiJ.WangQ.Cryo-EM structures"/>
 <result pre="ultraviolet lightâ€�based photochemical treatmentTransfusion5620162948295227805261 80AthertonJ.KratzingC.FisherA.The effect of ascorbic acid on" exact="infection" post="of chick-embryo ciliated tracheal organ cultures by coronavirusArch. Virol.561978195199205194"/>
 <result pre="81NonneckeB.McGillJ.RidpathJ.SaccoR.LippolisJ.ReinhardtT.Acute phase response elicited by experimental bovine diarrhea virus (BVDV)" exact="infection" post="is associated with decreased vitamin D and E status"/>
 <result pre="82BeckM.A.KolbeckP.C.RohrL.H.ShiQ.MorrisV.C.LevanderO.A.Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3" exact="infection" post="of miceJ. Nutr.12419943453588120653 83MoritaM.KubaK.IchikawaA.NakayamaM.KatahiraJ.IwamotoR.The lipid mediator protectin D1 inhibits"/>
 <result pre="subsets in measles. Depressed helper/inducer subpopulation reversed by in vitro" exact="treatment" post="with levamisole and ascorbic acidJ. Clin. Invest.7219839719806604071 94LuoC.LuoH.ZhengS.GuiC.YueL.YuC.Nucleocapsid protein"/>
</results>
